Advantages of “Soft Steroids” in the Treatment of Inflammatory Eye Diseases. Оverview

The purpose to assess the benefits of using soft steroids in the treatment of inflammatory eye disorders according to literature data.

Methods. The literature review concerning the administration of the gluco-corticosteroids and combination drugs based on gluco-corticosteroid for the treatment of inflammatory eye disorders. Both Russian and foreign sources for the 1980–2021 period were analyzed.

The results. The combination drugs containing anti-infective drugs and gluco-corticosteroids are actively applied for the treatment of inflammatory eye disorders. That exerts joint ethiopathogenetic effect on the disorder. However, gluco-corticosteroid being a part of such drugs (predominantly dexamethasone) as often as not leads to ocular hypertension. In order to deal with this problem the so-called soft steroids (also classified as gluco-corticosteroids) were introduced. They lessen the possibility of the ocular hypertension and are marked by high efficiency and increased safety profile. One of the representatives of soft steroids is fluorometholone. There is a large evidential base in the modern literature that confirms much lesser influence of fluorometholone on ocular pressure if compared to dexamethasone. At the same time, dexamethasone has a higher anti-inflammatory activity, while on the other hand, its systemic immunosuppressive activity is lower. What is more, in terms of influence on the ocular surfaces, dexamethasone has an additional advantage which is causing mucin expression in conjuctival and corneal epithelium. The above mentioned merits of dexamethasone served as basis for its inclusion into the combination drug called Floas-T which is essentially the combination of tobramycin 0.3 % and fluorometholone 0.1 %. It is used in the treatment of inflammatory eye diseases and diseases of eye appendages, as well as for profylaxis of the diseases in the postoperative period.

Conclusion. Combination drugs containing anti-infective components and gluco-corticosteroids seem to be highly promising for the treatment of inflammatory eye diseases. One of them worth highlighting is Floas-T classified as soft steroids containing tobramycin and fluorometholone. It compares to dexamethasone favourably in terms of efficiency, while contributing less to ocular hypertension.

1. Akopova E.B., Maychuk D.Yu., Loshkareva A.O., Simonova T.A. Analysis of character and resistance of bacterial microflora in patients with conjunctivitis and keratoconjunctivitis. Modern technologies in ophthalmology = Sovremennye tekhnologii v oftal’mologii. 2018;4:16–18 (In Russ.).

2. Yakovlev S.V. (ed.) Rational antimicrobial therapy: a guide for practitioners. Moscow: Litterra, 2015. 1040 p. (In Russ.).

3. Bikbov M.M., Babushkin A.E., Zajnutdinova G.H., Matyuhina E.N. Analysis of the dynamics of some inflammatory diseases of the anterior segment of the eye in the Republic of Bashkortostan. Russian Medical Journal. Clinical Ophthalmology = Rossiyskiy medicinskiy zhurnal. Klinicheskaya oftal’mologiya. 2016;1:34–39 (In Russ.).

4. Yakovlev V.P., Yakovlev S.V. (ed.) Rational antimicrobial pharmacotherapy. Moscow: Litterra, 2007. 284 p. (In Russ.).

5. Deev L.A., Bel’kova A.G., Malahova A.I., Vojtova S.P. The use of combined antibacterial agents in ophthalmology. Vestnik of the Smolensk State Medical Academy =Vestnik Smolenskoy gosudarstvennoy medicinskoy akademii. 2012;1:71–73 (In Russ.).

6. Kasparova E.A. Purulent corneal ulcers: etiology, pathogenesis, classification. Annals of ophthalmology = Vestnik Oftalmologii. 2015;131(5):87–97 (In Russ.). DOI: 10.17116/oftalma2015131587-97

7. Chernakova G.M., Maychuk D.Yu., Kleshcheva E.A., Loshkareva A.O., Semenova T.B. Guidelines for the Management of Patients with Herpetic Keratitis/Keratouveitis in the Long Term: from Problem to Solution. Ophthalmology in Russia = Oftal’mologiya. 2019;16(4):537–545 (In Russ.). DOI: 10.18008/18165095-2019-4-537-545

8. Kovalevskaya M.A., Majchuk D. Yu., Brzheskij V.V., Majchuk Yu.F., Okolov I.N. Red Eye Syndrome: A Practical Guide for Ophthalmologist. Majchuk D.Yu., ed. М., 2010. 108 p. (In Russ.).

9. Voroncova T.N., Mihajlova M.V., Brzheskij V.V., Azarova M.E., Smol’yaninova T.V. The effectiveness of combined antibacterial drugs in the treatment of inflammatory eye diseases in children. Russian ophthalmology of children = Rossiyskaya detskaya oftal’mologiya. 2013;4:27–29 (In Russ.).

10. Vitovskaya O.P. Medically induced glaucoma. Ophthalmology journal = Oftal’mologicheskie vedomosti. 2014;VII(3):58–62 (In Russ.).

11. Babu K., Mahendradas P. Medical Management of Uveitis — Current Trends. Indian Journal of Ophthalmology. 2013;61(6):277–284. DOI: 10.4103/03014738.114099

12. Akingbehin A.O. Comparative study of the intraocular pressure effects of fluorometholone 0.1 % versus dexamethasone 0.1 %. British journal of ophthalmology. 1983;67(10):661–663. DOI: 10.1136/bjo.67.10.661

13. Morrison E., Archer D.B. Effect of fluorometholone (FML) on the intraocular pressure of corticosteroid responders. British journal of ophthalmology. 1984;68(8):581– 584. DOI: 10.1136/bjo.68.8.581

14. Stewart R.H., Smith J.P., Rosenthal A.L. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate. Current eye research. 1984;3(6):835–839. DOI: 10.3109/02713688409000796

15. Yamauchi H., Iso T., Iwata H. Ocular anti-inflammatory and systemic immunosuppressive effects of topically applied fluorometholone. The Japanese Journal of Pharmacology. 1979;29(1):87–92. DOI: 10.1254/jjp.29.87

16. Pinto-Fraga J., López-Miguel A., González-García M. J. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress. A Randomized Controlled Clinical Trial. Ophthalmology. 2016;123:141–153. DOI: 10.1016/j.ophtha.2015.09.029

17. Avunduk A.M., Avunduk M.C., Varnell E.D., Kaufman H.E. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136(4):593–602. DOI: 10.1016/S0002-9394(03)00326-X

18. Taniguchi J., Sharma A. Fluorometholone modulates gene expression of ocular surface mucins. Acta Ophthalmol. 2019;97:e1082–e1088. DOI: 10.1111/ aos.14113

19. Yani E.V., Golikova V.A. Complex Approach to the Bacterial Corneal Ulcers Treatment. Ophthalmology in Russia = Oftal’mologiya. 2020;17(4):796–803 (In Russ.). DOI: 10.18008/1816-50952020-4-796-803

20. Pronkin I.A., Maychuk D.Yu. Recerrent corneal erosion: etiologe, pathogenesis, diagnosis and treatment. Fyodorov Journal of Ophthalmic Surgery= Oftal’mokhirurgiya. 2015;1:62–67 (In Russ.).